Sharrol Bachas is a biophysicist, structural biologist, and protein engineer working at the intersection of AI and protein design. He is Co-founder and Chief Scientific Officer at Onava, where he is building a next-generation platform for therapeutic protein design—combining generative models, protein engineering, structural biology, and a proprietary high-throughput wet lab to rapidly iterate on antibodies, peptides, and miniproteins for design and optimization.

Prior to founding Onava, Sharrol led AI-driven antibody engineering programs at Absci, directed scaled AI–wet lab implementation of protein design workflows at EvolutionaryScale, and helped shape foundational infrastructure for integrating structural biology with machine learning in drug discovery. His work spans de novo design, structural grafting, display-based screening, and biophysics, with a strong emphasis on human-in-the-loop design cycles.

Sharrol earned his Ph.D. in Biophysics and Biophysical Chemistry from Johns Hopkins University School of Medicine, and completed his postdoctoral research at the NIH, focusing on structure–function relationships of proteins and RNAs using X-ray crystallography.